A 30-year-old Connecticut man was killed early Sunday morning, Oct. 20, after driving the wrong way on a highway and crashing into an oncoming car in New Haven County, authorities said. Aron Tyrell ...

The “Thanksgiving grandma,” who accidentally texted a dinner invitation to a teen she’d never met, invited him anyway and ...

Stephen Knight has saved thousands of animals from ending up in shelters. But 13 years ago, he was just trying to save himself.Knight, whose nonprofit provides fost ...

No serious adverse events; no grade 3 or higher adverse events reported Initial data from BEACON study expected week of ...

The clinic provides functional training and recommendations for assistive devices, allowing patients to adapt to their ...

Marstacimab is a human monoclonal immunoglobulin G type 1 antibody that enhances coagulation by targeting the Kunitz 2 domain of tissue factor pathway inhibitor.

The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

LTR Pharma’s pivotal trial for its novel intranasal formulation SPONTAN demonstrates it outperforms traditional oral erectile ...

Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ ...

The U.S. Food and Drug Administration approved Pfizer's once-a-week injection for the two main types of a rare bleeding ...

Introduction Fluoroquinolones can cause severe collagen-associated adverse effects, potentially impacting the pulmonary ...